Table 3.
Author | Marginal Analysis | Statistical Analysis | Sensitivity Analysis | ICER | Scope of Study | ||
---|---|---|---|---|---|---|---|
Cost | Outcome | Accrued over time | |||||
Vermeer F, et al. 198815 | Not Stated | Stated | Not Stated | Not Stated | Yes | Yes | No Discounting Stated |
Levin LA, et al. 199216 | Not Stated | Stated | Not Stated | Stated (Costeffectiveness and cost-utility ratios) | Yes | Yes (QALY as cost-utility measure) | Discounting Stated 5% |
Machecourt J, et al. 199317 | Not Stated | Stated | Stated | Stated | Yes | Yes | No Discounting Stated |
Rawles JM, 199718 | Stated (Marginal costs | Not Stated | Stated | Not Stated | Yes | Yes | No Discounting Stated |
Franzosi MG, et al. 199819 | Not Stated | Stated | Stated | Stated (Incremental costs for each extra life saved) | Yes | Yes | No Discounting Stated |
Lorenzon R, et al. 199820 | Not Stated | Stated | Stated | Stated (Cost per additional survivor) | Yes | Yes | No Discounting Stated |
Marcoff L, et al. 200921 | Not Stated | Stated | Stated | Stated (measured by LYG, QALY) | Yes | Yes | Discounting Stated 3% |
Welsh RC et al. 200922 | Not Stated | Stated | Stated | Stated (measured by LYG) | Yes | Yes | Discounting Stated 5% |